Stocks TelegraphStocks Telegraph
Stock Ideas

NKTR Stock Performance and Key Statistics

NASDAQ : NKTR

Nektar Therapeutics

$70.37
1.95+2.85%
At Close 4:00 PM
60.12
BESG ScoreESG Rating

stock performance chart

NKTR Fundamental Analysis

Based on recent data, Nektar Therapeutics (NKTR) shows an Average True Range (ATR) of 4.61 and an Enterprise Value of 463.63M. Its average trading volume over the past 3 months is 1.09M, indicating liquidity. These fundamental metrics provide insight into NKTR's underlying financial health and market activity.

ATR4.61
Enterprise Value463.63M
Avg Vol (3 Months)1.09M
Avg Vol (10 Days)1.1M

NKTR Technical Analysis Indicators

Nektar Therapeutics (NKTR) technical indicators as of February 26, 2026: the SMA 20 is 27.51%, SMA 50 at 48.93%, and SMA 200 at 78.13%. The RSI 14 value is 71.09, suggesting its current momentum. These technical analysis signals help assess NKTR's price trends and potential future movements.

SMA 2027.51%
SMA 5048.93%
SMA 20078.13%
RSI 1471.09

NKTR Stock Performance Overview

Nektar Therapeutics (NKTR) stock performance overview as of February 26, 2026: The 52-week high is $75.67 (currently -7% below), and the 52-week low is $0.432 (currently 16,189.35% above). Over the past year, NKTR's performance is 170.87%, compared to the S&P 500's 10.91% change.

52-Week High75.67
52-Week High Chg-7.00%
52-Week Low0.432
52-Week Low Chg+16,189.35%
S&P 500 52-Week Chg10.91%

Nektar Therapeutics (NKTR) Historical Stock Performance

According to market data, Nektar Therapeutics (NKTR) stock's recent performance metrics show that over the last month, NKTR is -20.25%, with a Year-to-Date (YTD) performance of -14.31%. Over the past year, the stock has seen a 170.87% change. These figures summarize NKTR's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High75.6775.6775.6775.6775.6775.67
Low68.233.433.426.450.43233.4
Performance-6.55%-20.25%-37.29%+46.15%+170.87%-14.31%

Industry Analysis and Valuation

According to current financial data, NKTR stock's P/E (TTM) ratio is -8.19, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for NKTR, including P/S (22.82), P/B (11.63), and P/FCF (-7.51), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationNKTRSector MedianIndustry AvgS&P 500
P/E (TTM)-8.19-1.23-5.1632.59
P/S (TTM)22.823.71464.925.98
P/B (TTM)11.63115.6495.26
P/FCF (TTM)-7.51-0.18-253.2830.85

Frequently Asked Questions

How is NKTR price-to-earnings ratio currently?
NKTR has a current P/E ratio of -8.19
How are NKTR's price-to-sale and price-to-book ratios?
The NKTR stock has a trailing twelve month price-to sales (P/S) ratio of 22.82 while its price-to-book (P/B) value is 11.63.
Is Nektar Therapeutics's price-to-cashflow ratio high or low?
NKTR's price-to-free-cashflow (P/FCF) ratio is -7.51, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for NKTR?
Based on NKTR's recent bid, its distance from 20 days simple moving average is 27.51%. It is 48.93% apart from 50 days simple moving average, and it is 78.13% apart from 200 days simple moving average.
What is the 52-week price range for NKTR?
The 52-week high for NKTR is $74.89 which is -7% away from the current price level whereas the distance of that from the 52-week low of $6.45 stands at 16,189.35%.
An overview of NKTR's stock performance: how did it fare?
The performance of NKTR stock was not encouraging with most of its significant price indicators in red. Nektar Therapeutics(NASDAQ: NKTR) shares have moved upward +2.85% or $1.95 in the latest trading session and have lost -14.31% year-to-date (YTD). The stock has gained nearly 170.87% over the past year. After moving -37.29% over the trailing 3-month period, the stock is 46.15% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -6.55% a week and -20.25% a month.
What is NKTR's 14-day relative strength index (RSI)?
The current 14-day RSI for NKTR stock is 71.09. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For NKTR, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Nektar Therapeutics (NKTR) has a 14-day ATR of 4.61.
What is NKTR's current enterprise value?
After closing at $68.42 with 20.34M of its shares outstanding, the current enterprise value of NKTR is roughly 463.63M.
Over the past year, how has the stock price of NKTR changed?
Nektar Therapeutics (NASDAQ: NKTR) is up 170.87% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 10.91%. NKTR stock price is also down -14.31% on its value in year-to-date trading.
What is the average trading volume for NKTR shares?
The number outstanding shares of NKTR is 20.34M, and of these 92.51% shares are freely available for trading. On average, NKTR stock has traded 1.1M shares per day for the past 10 days. A total of 935.63K shares changed hands during the last trading session with the average session volume of 1.09M shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph